Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad[I/PPT-E1A] adjuvant intraprostatic oncolytic adenovirus study before radical prostatectomy
NL-OMON43563Phase 1Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2013
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of Ad[I/PPT-E1A] in prostate cancer (PCa) (3 arms), sponsored by Erasmus MC. Primary endpoint: Dose-limiting toxicity. Planned start Sep 2013; status: not yet recruiting.
02
Drugs
Ad[I/PPT-E1A]
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON43563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43563.